Guidelines for the pharmacological treatment of COVID-19. The task-force/consensus guideline of the Brazilian Association of Intensive Care Medicine, the Brazilian Society of Infectious Diseases and the Brazilian Society of Pulmonology and Tisiology
Rev. bras. ter. intensiva; 32 (2), 2020
Different therapies are currently used, considered, or proposed for the treatment of COVID-19; for many of those therapies, no appropriate assessment of effectiveness and safety was performed. This document aims to provide scientifically available evidence-based information in a transparent interpretatio...
Infecciones por Coronavirus/tratamiento farmacológico, Aminoquinolinas/uso terapéutico, Oseltamivir/uso terapéutico, Lopinavir/uso terapéutico, Ritonavir/uso terapéutico, Corticoesteroides/uso terapéutico, Heparina/uso terapéutico, Antibacterianos/uso terapéutico, Betacoronavirus/efectos de los fármacos, Neumonía Viral/tratamiento farmacológico, Pandemias/prevención & control